Mary Ann Liebert: New Strategy to Enhance Gene Therapy for Sickle Cell Disease
November 20, 2024
November 20, 2024
NEW ROCHELLE, New York, Nov. 20 (TNSres) -- Mary Ann Liebert Inc. issued the following news release:
Researchers described a promising new approach for using gene therapy to treat sickle cell disease in the peer-reviewed journal Human Gene Therapy. To improve the efficacy of gene therapy when using anti-sickling beta globin gene transfer, they added cyclosporin (CsH) to increase transduction by inhibiting lentiviral restriction factors. Click here (https://www.liebertpub.com/doi/10. . . .
Researchers described a promising new approach for using gene therapy to treat sickle cell disease in the peer-reviewed journal Human Gene Therapy. To improve the efficacy of gene therapy when using anti-sickling beta globin gene transfer, they added cyclosporin (CsH) to increase transduction by inhibiting lentiviral restriction factors. Click here (https://www.liebertpub.com/doi/10. . . .